|
Press Releases
| |
|
Displaying releases:
1-15 | 16-30 | 31-45 | 46-60 | 61-75 | 76-90 | 91-100
|
| |
May-09-2007
|
Palatin Technologies And King Pharmaceuticals Announce Plan To Present Results Of Bremelanotide Phase 2b Studies In Men With Erectile Dysfunction
|
| |
May-09-2007
|
Palatin Technologies, Inc. Reports Fiscal Year 2007 Third Quarter Results;
Conference Call and Webcast May 10, 2007 at 10:00 a.m. EDT |
| |
Apr-11-2007
|
Palatin Technologies To Present At The CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference |
| |
Feb-26-2007
|
Palatin Technologies And King Pharmaceuticals Announce Presentation Regarding Clinical Study Evaluating Bremelanotide In Post-Menopausal Female Sexual Dysfunction Patients |
| |
Feb-16-2007
|
Palatin Technologies, Inc. Completes $27.5 Million Offering |
| |
Feb-13-2007
|
Palatin Technologies, Inc. To Raise $ 27.5 Million In Common Stock Offering |
| |
Feb-09-2007
|
Palatin Technologies, Inc. Reports Fiscal Year 2007 Second Quarter Results;
Conference Call and Webcast February 13, 2007 at 10:00 a.m. EST |
| |
Feb-08-2007
|
Palatin Technologies To Present At The BIO CEO & Investor Conference |
| |
Jan-31-2007
|
Astrazeneca And Palatin Technologies Announce Worldwide Collaboration To Discover, Develop And Commercialise Obesity Compounds |
| |
Jan-31-2007
|
Palatin Technologies To Hold Conference Call And Webcast To Discuss Worldwide Collaboration With AstraZeneca |
| |
Dec-20-2006
|
Palatin Technologies And King Pharmaceuticals Complete Enrollment In Pre-Menopausal Cohort Of A Phase 2 Clinical Trial Evaluating Bremelanotide In Pre- And Post-Menopausal Female Sexual Dysfunction Patients
|
| |
Dec-05-2006
|
Palatin Technologies Presents At The 9th European Society for Sexual Medicine (ESSM) Congress |
| |
Nov-10-2006
|
Palatin Technologies, Inc. Reports Fiscal Year 2007 First Quarter Results;
Conference Call and Webcast Being Held Today at 10:00 a.m. EST |
| |
Nov-07-2006
|
Palatin Technologies to Report First Quarter, Fiscal Year 2007 Financial Results; Conference Call and Webcast on November 10, 2006 |
| |
Nov-06-2006
|
Palatin Technologies and King Pharmaceuticals Report Results for Two Phase 2B Clinical Trials Evaluating Bremelanotide in Male Erectile Dysfunction Patients |
| |
 |
|
|
